BB Biotech AG
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BB Biotech AG generated cash of $218,276,000, which is more than the previous year. Cash used in financing activities reached the amount of -$220,213,000 last year. Net change in cash is therefore -$1,447,000.
Cash Flow
| 2014 | 1.47B | -1.34B | -157.28M |
|---|---|---|---|
| 2015 | 652.81M | -600.42M | -38.97M |
| 2016 | -802.06M | 917.46M | -126.80M |
| 2017 | 687.50M | -424.03M | -262.97M |
| 2018 | -471.34M | 579.13M | -93.90M |
| 2019 | 215.02M | 0 | -205.21M |
| 2020 | 262.44M | 0 | -284.48M |
| 2021 | -94.78M | 0 | 91.76M |
| 2022 | -357.81M | 588.94M | -233.27M |
| 2023 | 218.27M | 0 | -220.21M |
BION.SW Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.94M | 2.83M | 6.81M | 30.70M | 22.07M | 10.73M | 10.22M | 21.05M | 8.96M | 43.69M |
Operating activities | ||||||||||
Net income | -206.60M | -357.81M | -404.80M | 691.17M | 677.43M | -471.34M | 687.50M | -802.06M | 652.81M | 1.47B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 25K | 118K | 118K | 93K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 25K | 118K | 118K | 93K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 218.27M | -357.81M | -94.78M | 262.44M | 215.02M | -471.34M | 687.50M | -802.06M | 652.81M | 1.47B |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 588.94M | 0 | 0 | 0 | 579.13M | -424.03M | 917.46M | -600.42M | -1.34B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 9.65M | 20K | 0 | 0 | 18.71M | 43.93M | 133.37M | 80.40M |
Payments for dividends | -156.31M | -212.24M | -199.44M | -188.36M | -168.97M | -182.82M | -152.06M | -160.48M | -130.07M | -79.42M |
Repurchases of common stock | 0 | -27.30M | -9.45M | -8.26M | 0 | 0 | -19.08M | -54.16M | -172.26M | -98.26M |
Repayments of term debt | -58.1M | 0 | -292M | -87M | 0 | 0 | -110M | 0 | 130M | -60M |
Cash used in financing activities | -220.21M | -233.27M | 91.76M | -284.48M | -205.21M | -93.90M | -262.97M | -126.80M | -38.97M | -157.28M |
Net Change In Cash | -1.44M | -887K | -3.98M | -23.89M | 8.63M | 11.34M | 501K | -10.83M | 12.09M | -34.73M |
Cash at end of period | 501K | 1.94M | 2.83M | 6.81M | 30.70M | 22.07M | 10.73M | 10.22M | 21.05M | 8.96M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |